- Home
- KOSS vs ANVS Comparison
KOSS vs ANVS Comparison
Compare KOSS & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- ANVS
- Stock Information
- Founded
- KOSS 1953
- ANVS 2008
- Country
- KOSS United States
- ANVS United States
- Employees
- KOSS N/A
- ANVS N/A
- Industry
- KOSS Consumer Electronics/Appliances
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- ANVS Health Care
- Exchange
- KOSS Nasdaq
- ANVS Nasdaq
- Market Cap
- KOSS 63.0M
- ANVS 110.4M
- IPO Year
- KOSS N/A
- ANVS 2020
- Fundamental
- Price
- KOSS $7.34
- ANVS $9.64
- Analyst Decision
- KOSS
- ANVS Strong Buy
- Analyst Count
- KOSS 0
- ANVS 6
- Target Price
- KOSS N/A
- ANVS $29.67
- AVG Volume (30 Days)
- KOSS 183.8K
- ANVS 341.4K
- Earning Date
- KOSS 11-08-2024
- ANVS 11-06-2024
- Dividend Yield
- KOSS N/A
- ANVS N/A
- EPS Growth
- KOSS N/A
- ANVS N/A
- EPS
- KOSS N/A
- ANVS N/A
- Revenue
- KOSS $12,265,069.00
- ANVS N/A
- Revenue This Year
- KOSS N/A
- ANVS N/A
- Revenue Next Year
- KOSS N/A
- ANVS N/A
- P/E Ratio
- KOSS N/A
- ANVS N/A
- Revenue Growth
- KOSS N/A
- ANVS N/A
- 52 Week Low
- KOSS $2.27
- ANVS $4.53
- 52 Week High
- KOSS $18.73
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- KOSS 50.17
- ANVS 58.70
- Support Level
- KOSS $7.00
- ANVS $9.00
- Resistance Level
- KOSS $7.83
- ANVS $10.54
- Average True Range (ATR)
- KOSS 0.44
- ANVS 0.81
- MACD
- KOSS -0.01
- ANVS 0.12
- Stochastic Oscillator
- KOSS 32.26
- ANVS 74.57
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.